What is USCB Financial Holdings, Inc.'s granted (in shares)?

USCB Financial Holdings, Inc. (USCB) reported granted (in shares) of 0 in Q4 2025.

What does granted (in shares) mean?

The total number of stock option shares granted to employees and directors during the reporting period. This metric provides insight into the company's equity-based incentive strategy and potential future dilution.

USCB Financial Holdings, Inc. USCB Granted (in shares)

Granted (in shares) at other companies

CNB FinancialCCNE

0—

WingstopWING

0—

Oruka Therapeutics, Inc.ORKA

1.5M-12.6%

LivaNovaLIVN

957.7K+31.3%

The Hanover Insurance GroupTHG

148.1K+5.5%

GenpactG

0—

Other financials

Income statement

See full

Revenue$26.2M+14.7%

Net income$9.4M+22.1%

EPS (diluted)$0.51+34.2%

Balance sheet

See full

Cash & equivalents$79.0M-19.4%

Total debt$4.8M-38.3%

Total equity$223.2M-0.8%

Total assets$2.8B+6.3%

Cash flow

See full

Operating cash flow$15.3M+4.4%

CapEx$320.0K+596%

Free cash flow$15.0M+2.6%

Valuation

See full

Market cap$363.27M+13.5%

Enterprise value$289.06M+25.8%

P/E13.1×+1.5×

P/S3.9×+0.2×

Profitability

See full

Net margin29.7%-1.8pp

FCF margin55.3%—

Returns & leverage

See full

Return on equity12.4%-0.8pp

Debt / equity0×0.0×

Where this comes from

Reported directly by USCB Financial Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.

The official record: USCB Financial Holdings, Inc.’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about USCB Financial Holdings, Inc.'s granted (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is USCB Financial Holdings, Inc.'s granted (in shares)?: USCB Financial Holdings, Inc. (USCB) reported granted (in shares) of 0 in Q4 2025.
What does granted (in shares) mean?: The total number of stock option shares granted to employees and directors during the reporting period. This metric provides insight into the company's equity-based incentive strategy and potential future dilution.